*By Jacqueline Corba*
This summer season, CBD-infused beverages were among the hottest new drinks on the market. The drinks, said Dirty Lemon's CEO Zak Normandin, offer an alternative way for some to just chill ー sans alcohol, and sans the traditional marijuana-induced high.
"A lot of consumers are actually replacing ... an alcoholic beverage \[with this\]. So at the end of the day you've had a long day at work incorporating this product into your daily routine to just relax," Normandin, also a co-founder of the beverage company, told Cheddar's CannaBiz on Tuesday.
Dirty Lemon, which launched in 2015 with a charcoal-infused lemon-flavored beverage called a detox "elixir," introduced its first CBD drink this July. The new product sold out of the first batch, roughly 20,000 bottles, in only two days.
"It's been challenging for us to keep up with demand," Normandin said. "People want to experience it for themselves."
Normandin said the combination of ingredients in a ready-to-drink format is driving the success of his company's beverage products and his new CBD drink, which uses cannabidiol produced by cannabis brand [Beboe](https://cheddar.com/videos/the-hermes-of-marijuana-wants-to-bring-you-cannabis).
Dirty Lemon is just one example of many companies that want to capitalize on the benefits of this marijuana extract, which does not actually contain THC or produce a high.
"It's a very crowded field and there is a lot of competition," Green Market Report CEO and editor-in-chief Debra Borchardt told Cheddar Tuesday.
CBD maker Charlotte's Web went public on the Canadian Securities Exchange [last week](https://www.newcannabisventures.com/charlottes-web-ipo-and-secondary-offering-boosted-to-16-45-million-shares-as-underwriters-exercise-over-allotment-option/). Its products are sold in 2,700 retail locations and the company is looking to triple its annual revenue this year. Borchardt said the company has already been able to capture 14 percent of the market.
And investors are taking note ー the stock surged more than 13 percent Tuesday, its third day of trading on the public market.
This is only the beginning for CBD products on the market, Borchardt said.
"You're going to be seeing people buying CBD water, and they are going to feel good. It's a wellness thing."
For full interview [click here](https://cheddar.com/videos/dirty-lemon-adds-cbd-to-its-beverage-menu).
Dubbed the "Ethereum Killer," Solana is known for its super-fast, low-cost transactions, which has proven attractive to defi companies looking to scale up quickly.
Chanda Smith Baker, Chief Impact Officer & SVP at The Minneapolis Foundation, joins ChedHER to discuss how the foundation is driving action for the greatest civic, social, and economic needs and gives advice for others seeking a career in the nonprofit industry.
Stax Payments recently announced a $245 million funding round. Suneera Madhani, CEO and Founder of Stax Payments and Host and Producer of 'CEO School' the podcast, joins ChedHER to discuss how to get more female founders to break $1 million in revenue.
Dr. Kat Cohen, Founder and CEO of IvyWise, talks about how the higher education industry has evolved over the past 20 years, and what to consider as the college decision deadline approaches.
An estimated five billion people lack access to affordable and safe surgical care around the world. For World Health Day, Cheddar News spoke with Kristie Magee Porcaro of Operation Smile, a nonprofit organization assisting with cleft lip and palate surgeries, about how they work to better it around the globe.
Ketanji Brown Jackson was confirmed to the U.S. Supreme Court, House Speaker Nancy Pelosi has COVID< and Miami has outdone itself with a shiny crypto bull. Here is all the news you Need2Know for Friday, April 8, 2022.
There has been notable disagreement in the medical community about a fourth COVID-19 vaccine dose. The FDA last week authorized a second booster dose for older and immunocompromised individuals, as some agency officials did not support the idea. The FDA made the decision without meeting with its advisory committee, as it had ahead of its recommendations on the previous COVID-19 vaccine doses.
The CDC followed in the footsteps of the FDA and authorized a fourth dose as well. Reports say the agency also did not discuss the move with its own advisory team of vaccine experts. Now, a growing number of doctors are speaking out against the decisions - leaving people confused about whether they should get another vaccine dose. Dr. Julie Morita, a member of the CDC's advisory committee to the director, and the executive vice president of the Robert Wood Johnson Foundation, joins Cheddar News' Closing Bell to discuss.
Connie Babikian, President of The Pillow Bar, joins Cheddar Innovates to discuss how everyone can benefit from a pillow customized to their unique way of sleeping, what research goes into making a pillow, and how sleep can impact our mental and physical health.
